China Probes Novo Nordisk

mia.burns Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk, the world’s biggest maker of insulin, in the latest sign of a widening investigation ...

Celgene’s blood cancer therapy nabs European approval

Emily Mullin Celgene has received the stamp of approval from the European Commission for its oral medication pomalidomide, in combination with the steroid dexamethasone, for the treatment ...

European Commission grants J&J, Celgene blood cancer approvals

Carly Helfand The European Commission was good to blood cancer drugmakers this week, granting multiple myeloma approvals for Johnson & Johnson's Velcade and Celgene's Imnovid. FiercePharma ...

Online Legal Resource Provides Update for Actos Bladder Cancer Lawsuits

mia.burns Actos Lawsuits Alleging Bladder Cancer Update: Resource4thePeople Reports Judge Continues to Move Multidistrict Litigation Forward San Diego, CA (PRWEB) August 09, ...

Biotech Ruthigen seeks IPO boost for preclinical hope

Ryan McBride With the IPO market increasingly appetizing to all manner of biotech companies, the little-known outfit Ruthigen has filed paperwork to raise up to $ 26.7 million in a ...

Sun has terrific quarter, except for that Pfizer thing

Eric Palmer Sun's sales in the U.S. were up 28%, and it posted a profit of $ 204.8 million for the quarter–that is, before that one thing with Pfizer. Of course, that one ...

Dainippon Sets up Regenerative and Cellular Medicine Office

mia.burns Dainippon Sumitomo Pharma To Set Up the Regenerative & Cellular Medicine Office Osaka, Japan, August 9, 2013 —– Dainippon Sumitomo Pharma Co., Ltd. ...

Onyx CEO challenges Amgen-only talk in buyout process

Ryan McBride Onyx Pharmaceuticals CEO Tony Coles has held his cards about his company's sales process close to the vest FierceBiotech News

Allergan takes latest IP hit as India revokes 2 patents

Carly Helfand According to The Economic Times, India's patent appeals board revoked the patents covering glaucoma treatments Ganfort and Combigan, both used to reduce pressure inside ...

EC Approves Teva’s Lonquex

mia.burns Teva Receives European Marketing Authorization for Lonquex® (XM22 lipegfilgrastim)   JERUSALEM–(BUSINESS WIRE)–Aug. 8, 2013– Teva Pharmaceutical ...

Is the biotech IPO frenzy headed for a crack-up?

John Carroll FierceBiotech News

Onyx CEO dismisses rumors that Amgen alone is still in the hunt

Eric Palmer Amgen reportedly raised its bid for Onyx Pharmaceuticals this week 10 bucks a share to $ 130, valuing the company at $ 9.5 billion and driving out other interested ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS